Evidence map›Paper›PMID 35056690›Full record

ReviewMolecules (Basel, Switzerland)2022

Impact of Graphene Derivatives as Artificial Extracellular Matrices on Mesenchymal Stem Cells.

Rabia Ikram, Shamsul Azlin Ahmad Shamsuddin, Badrul Mohamed Jan, Muhammad Abdul Qadir, George Kenanakis, Minas M Stylianakis, Spiros H Anastasiadis

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Electrostrategies in orthopaedic research.Biomaterials translational · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Research on Graphene and Its Derivatives in Oral Disease Treatment.International journal of molecular sciences · 2022
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Rabia IkramDepartment of Chemical Engineering, University of Malaya, Kuala Lumpur 50603, Malaysia.ORCID 0000-0003-1224-9818
Shamsul Azlin Ahmad ShamsuddinInstitute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur 50603, Malaysia.ORCID 0000-0001-7983-6502
Badrul Mohamed JanDepartment of Chemical Engineering, University of Malaya, Kuala Lumpur 50603, Malaysia.
Muhammad Abdul QadirInstitute of Chemistry, University of the Punjab, Lahore 54590, Pakistan.
George KenanakisInstitute of Electronic Structure and Laser, Foundation for Research and Technology-Hellas, GR-70013 Heraklion, Greece.ORCID 0000-0001-5843-3712
Minas M StylianakisInstitute of Electronic Structure and Laser, Foundation for Research and Technology-Hellas, GR-70013 Heraklion, Greece.ORCID 0000-0002-6718-3804
Spiros H AnastasiadisInstitute of Electronic Structure and Laser, Foundation for Research and Technology-Hellas, GR-70013 Heraklion, Greece.ORCID 0000-0003-0936-1614
University of Malaya · MYFoundation for Research and Technology Hellas · GRHellenic Mediterranean University · GRUniversity of the Punjab · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thanks to stem cells' capability to differentiate into multiple cell types, damaged human tissues and organs can be rapidly well-repaired. Therefore, their applicability in the emerging field of regenerative medicine can be further expanded, serving as a promising multifunctional tool for tissue engineering, treatments for various diseases, and other biomedical applications as well. However, the differentiation and survival of the stem cells into specific lineages is crucial to be exclusively controlled. In this frame, growth factors and chemical agents are utilized to stimulate and adjust proliferation and differentiation of the stem cells, although challenges related with degradation, side effects, and high cost should be overcome. Owing to their unique physicochemical and biological properties, graphene-based nanomaterials have been widely used as scaffolds to manipulate stem cell growth and differentiation potential. Herein, we provide the most recent research progress in mesenchymal stem cells (MSCs) growth, differentiation and function utilizing graphene derivatives as extracellular scaffolds. The interaction of graphene derivatives in human and rat MSCs has been also evaluated. Graphene-based nanomaterials are biocompatible, exhibiting a great potential applicability in stem-cell-mediated regenerative medicine as they may promote the behaviour control of the stem cells. Finally, the challenges, prospects and future trends in the field are discussed.

Indexed as

Cell DifferentiationExtracellular MatrixGraphiteMesenchymal Stem CellsTissue ScaffoldsAnimalsBiocompatible MaterialsCell ProliferationHumansNanostructuresRegenerative MedicineTissue EngineeringBiocompatible MaterialsGraphitegraphene oxidemesenchymal stem cellsnanotechnologytissue engineering

Identifiers

PMID35056690
PMCPMC8781794
OpenAlexW4205217715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.